This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Known as the negotiators between health plans, pharmacies and drug companies, pharmacy benefit managers are currently entangled in a national conversation about reform. The pharma industry has long blamed PBMs for rising drugprices, pointing to opaque rebate and profit structures , and proposed policy shifts could take them to task.
This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs.
According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drugpricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drugprices to those of other nations.
This is especially critical for temperature-sensitive biologics and vaccines, where maintaining proper storage conditions ensures product viability and regulatory compliance. In some cases, these events might be entirely unpredictable, forcing them to adapt product strategies with little to no advanced preparation.
and outperformed maternal vaccines in public health programs. Vaccines to treat RSV normally start in early fall, and having these additional shipments in advance is expected to give healthcare providers (HCPs) an additional assurance and confidence. Sanofi and AstraZeneca have tripled production capacity to meet growing demand.
The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. The 340B DrugPricing Program has long been a contentious issue for pharma. Please let us know if you have feedback. By Kelly Bilodeau A day in the life of GSK’s U.S.
Most Popular FDA investigating Elevidys safety; Nektar shares spike on eczema data Kymera adds Gilead as research partner, while advancing new candidate with Sanofi Oz hints at impending CMS rule to force drugprice transparency Hundreds of laid-off HHS staff have been reinstated, RFK Jr. You can unsubscribe at anytime.
How will RFK Jr’s American dream for vaccines play out? July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Piramal Pharma Solutions Lexington expansion groundbreaking.
The company didn’t provide specifics, but said in a Monday statement that drug recipients had “statistically significant and clinically meaningful improvements” on those assessments, and achieved “near normal ranges” across studied symptoms. The most common adverse events reported were insomnia as well as the sudden urge to urinate.
How will RFK Jr’s American dream for vaccines play out? This lost revenue is all the more painful to sponsors in an era of shortening periods of market exclusivity, particularly for small molecule drugs in the US due to changes enacted in the 2022 Inflation Reduction Act.
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. PTSD is a mental health condition that can occur after experiencing or witnessing a life-threatening or traumatic event. Credit: Andrey_Popov/Shutterstock.
Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription DrugPricing to American Patients,” with the objective of lowering drugprices, namely on branded drug products, for American consumers. How Does DrugPricing in the US Compare With Other Countries? REFERENCES 1.
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E.
How will RFK Jr’s American dream for vaccines play out? of equity shares from JB employees at the same price per share as offered to KKR. of equity shares from JB employees at the same price per share as offered to KKR.
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E.
Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals DrugPricing Gene Therapy An article from Dive Brief Organon drug for endometriosis falls short in mid-stage study Company executives had seen the drug as a potential multi-billion dollar opportunity in women’s health.
How will RFK Jr’s American dream for vaccines play out? This could transform the current drugpricing model, shifting from regular doses over time to a single treatment. However, the success or failure of treatments can all rest on logistics.
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E.
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.
How will RFK Jr’s American dream for vaccines play out? Adverse event reporting for CRS and neurological toxicity have remained stable,” the agency said in a statement. FDA has determined that the safe and effective use of CAR T cell immunotherapies for the indicated population can be assured without a REMS.
Most Popular FDA investigating Elevidys safety; Nektar shares spike on eczema data Kymera adds Gilead as research partner, while advancing new candidate with Sanofi Oz hints at impending CMS rule to force drugprice transparency Hundreds of laid-off HHS staff have been reinstated, RFK Jr. You can unsubscribe at anytime.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content